Back
First Trust Global Tact Cmdty Strat ETF Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
35
FTGC
First Trust Global Tact Cmdty Strat ETF
Last Price:
23.90
Seasonality Move:
-1.11%
Buy
52
SRPT
Sarepta Therapeutics
Last Price:
157.93
Seasonality Move:
18.65%
Sell
35
First Trust Global Tact Cmdty Strat ETF (FTGC)
is a Sell
Is First Trust Global Tact Cmdty Strat ETF a Buy, Sell or Hold?
- The current First Trust Global Tact Cmdty Strat ETF [FTGC] share price is $23.91. The Score for FTGC is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
- FTGC is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
52
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $157.74. The Score for SRPT is 52, which is 4% above its historic median score of 50, and infers lower risk than normal.
- SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
FTGC Stock Price Chart
What is First Trust Global Tact Cmdty Strat ETF's stock price today?
-
The First Trust Global Tact Cmdty Strat ETF share price today is $23.91
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FTGC is experiencing selling pressure, which indicates risk of future bearish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $157.74
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing slight selling pressure.
FTGC Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.04 | Sell |
Relative Strength Index (14 RSI): | 43.57 | Sell |
Chaikin Money Flow: | -202545 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (23.93 - 24.41) | Sell |
Bollinger Bands (100): | (23.32 - 24.4) | Buy |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 8.67 | Buy |
Relative Strength Index (14 RSI): | 68.69 | Buy |
Chaikin Money Flow: | -86202 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (114.06 - 147.06) | Buy |
Bollinger Bands (100): | (118.53 - 137.75) | Buy |
FTGC Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 24.14 | Sell |
20-day SMA: | 24.09 | Sell |
50-day SMA: | 24.19 | Sell |
200-day SMA: | 23.59 | Buy |
8-day EMA: | 24.07 | Sell |
20-day EMA: | 24.14 | Sell |
50-day EMA: | 24.11 | Sell |
200-day EMA: | 23.8 | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 149.53 | Buy |
20-day SMA: | 132.97 | Buy |
50-day SMA: | 129.56 | Buy |
200-day SMA: | 115.84 | Buy |
8-day EMA: | 150.26 | Buy |
20-day EMA: | 138.97 | Buy |
50-day EMA: | 131.58 | Buy |
200-day EMA: | 121.41 | Buy |
First Trust Global Tact Cmdty Strat ETF Earnings Growth & FTGC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $2.18 per share, an increase next quarter of $2.65 per share, an increase this year of $6.58 per share, and an increase next year of $8.28 per share.
First Trust Global Tact Cmdty Strat ETF Technical Analysis
Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |